Carmot Therapeutics' Grant - II Round

Carmot Therapeutics raised a round of funding on April 15, 2011. Investors include National Cancer Institute.

Carmot Therapeutics is applying its technology, Chemotype Evolution, to address unmet chemical needs in drug discovery, focusing on high-profile targets for which drug leads have been difficult to ide…

Articles about Carmot Therapeutics' Grant - II Round: